Sanjay J. Mathew, M.D. is the Department Head for Psychiatry and Behavioral Sciences at the Texas A&M University Naresh K. Vashisht College of Medicine. Mathew joins the Vashisht College of Medicine after 16 years with Baylor College of Medicine in Houston, where he most recently served as a tenured endowed professor and vice chair for research in the Menninger Department of Psychiatry & Behavioral Sciences. He was also director of the Mood & Anxiety Disorders Program, staff physician at the Michael E. DeBakey Veterans Affairs Medical Center, and a senior scientist at the Menninger Clinic.

Mathew is a graduate of Dartmouth College and Baylor College of Medicine. He trained as a resident in psychiatry at Columbia University/New York-Presbyterian Hospital and completed a postdoctoral research fellowship in mood and anxiety disorders at Columbia University and the New York State Psychiatric Institute. Before his time at Baylor, he served on the Icahn School of Medicine faculty at Mount Sinai, where he co-founded the Mood & Anxiety Disorders Program.

Mathew's research focuses on novel therapies for treatment-resistant mood/anxiety disorders and PTSD, particularly rapid-acting glutamate-modulating agents. Funders include NIMH, the VA, PCORI, and industry. He has authored 200+ manuscripts/chapters and serves on several editorial boards. A long-time ADAA member (Program Committee Chair, 2017-2018), he is also a member of ACNP and a board member of ASCP. A “Best Doctor” since 2011, he has received awards for psychopharmacology teaching.

Member since 2000; currently ADAA President and Chief Medical Officer.

Tanja Jovanovic, PhD is Professor and the David & Patricia Barron Chair for PTSD Neurobiology at Wayne State University. Former Director of the Grady Trauma Project, her research examines how traumatic experiences interact with neurophysiology, neuroendocrinology, and genetics in stress-related disorders in adults and children in high-risk populations.

Her lab employs psychophysiology (fear-potentiated startle, skin conductance, HRV) and brain imaging to identify biomarkers of PTSD risk and has developed novel human conditioning/inhibition/extinction paradigms. She is PI on multiple NIH grants and recipient of a BBRF Independent Investigator Award; she has published 100+ peer-reviewed papers.

Member since 2009; currently ADAA President Elect and member of the PTSD and Genetics & Neuroscience SIGs.

Why ADAA? ADAA is my home organization since my postdoc years—trainee-friendly, collaborative, and focused on career development and mentorship.

In 2025, Dr. Pizzagalli joined the University of California at Irvine as the Founding Director of the Noel Drury, M.D. Institute for Translational Depression Discoveries, a Distinguished Professor in the Department of Psychiatry and Human Behavior and the Department of Neurobiology and Behavior, and the Noel Drury MD Endowed Chair. He is also the Center Director for a Silvio O. Conte Center for Basic Translational Mental Health Research focused on the neurobiology of and novel treatment targets for depression. Until 12/2024, Dr. Pizzagalli was a Professor of Psychiatry at Harvard Medical School. Since 2024, he is also a Visiting Professor at the University of Oxford, UK. Dr. Pizzagalli received his M.A. (1995) and Ph.D. (1998) from the University of Zurich, Switzerland and did post-doctoral work at University of Wisconsin, Madison. From 2002-2010 he was a faculty member in the Department of Psychology at Harvard University, where he served as the John and Ruth Hazel Associate Professor of the Social Sciences. 

His work targets biomarkers of depression and treatment response, integrating behavioral, electrophysiological, neuroimaging, and molecular imaging approaches around anhedonia, stress sensitivity, and executive dysfunction. Dr. Pizzagalli has been an ADAA member since 2013 and joined the Board in 2024; currently ADAA Treasurer.

Jill M. Emanuele, PhD, ABPP is a board-certified clinical psychologist who is the Founder and Executive Director of Urban Yin Psychology, PLLC, in New York City. She previously served as Vice-President, Clinical Training and Senior Psychologist at the Child Mind Institute. She evaluates and treats youth and adults with mood and other psychiatric disorders, with a focus on complex presentations. 

Expertise includes CBT, DBT, RO-DBT, family therapy, and mindfulness; clinical implementation; supervision across disciplines; and leadership in building clinical training programs for youth-serving systems.

She earned BA degrees in Psychology and Music (University of Richmond) and a PhD in Clinical Psychology (George Mason). Predoc/postdoc training: LIJ/Northwell in NYC. Clinical experience includes LIJ-Hillside Hospital, Montefiore, and Bronx Children’s Psychiatric Center. She presents widely and has co-authored book chapters; she contributes to public education via TV, radio, internet, and podcasts.

Member since 2003. Dr. Emanuele is currently Board Secretary and is the 2026 Conference Committee Board Liaison.
She was a CDLP Clinical Track Chair and Conference/Membership Committee member.

Helen Blair Simpson, M.D., Ph.D. is Professor of Psychiatry in the Department of Psychiatry at Columbia University Irving Medical College (CUIMC), Director of the Center for the OCD and Related Disorders at the New York State Psychiatric Institute, and co-research director of the New York-Presbyterian Center for Youth Mental Health. Funded by NIMH since 1999, she uses clinical trials to identify the best treatments for anxiety and OCD and partners with neuroscientists to elucidate how the brain produces anxiety, obsessions, and compulsions.

She currently leads an NIMH-funded grant to identify brain signatures of OCD with global collaborators. She partners with New York State to train front-line clinicians in early detection and treatment of OCD. She serves as Associate Editor of JAMA Psychiatry and is Immediate Past President of ADAA. An advisor to WHO on OCD classification and author of the APA Practice Guidelines for OCD, Dr. Simpson works to transform care for people with anxiety and OCD.

Dr. Simpson graduated summa cum laude from Yale, completed the MD-PhD program at The Rockefeller University/Cornell (PhD in basic neuroscience), and trained in psychiatry at Columbia University/New York-Presbyterian Hospital. She joined the Anxiety Disorders Clinic in 1996, later served as its Director (2006-2016), then Vice Chair for Research at Columbia Psychiatry and Director of Psychiatric Research at NYSPI (2017-2022), and Interim Chair of Psychiatry/Interim Director of NYSPI (2022-2023).

Member of ADAA since 2003; currently ADAA Immediate Past President.

Ken Goodman, LCSW specializes in anxiety disorders and OCD. He authored and produced The Anxiety Solution Series (12-hour audio program), Break Free from Anxiety (coloring self-help), and The Emetophobia Manual. He presents at universities and organizations including USC, UCLA, ADAA, and the International OCD Foundation.

Ken earned his BA and MSW from UCLA and treats children, teens, and adults in Los Angeles. He serves on the ADAA Board of Directors and is the Board liaison to ADAA’s Public Education Committee. He has written several articles and appears in ADAA webinars and videos. Member since 2009.

Krystal M. Lewis, PhD is a licensed Clinical Psychologist and Co-Director of Education with the Section on Development and Affective Neuroscience (SDAN) at NIMH and Director of the Clinical Psychology Externship Program at NIH. Her group studies how information processing varies across youth with anxiety/depression using neuroimaging and biobehavioral methods.

She completed internship and fellowship at Lurie Children’s Hospital in Chicago. Dr. Lewis uses culturally informed, developmentally appropriate, evidence-based approaches; her interests focus on mechanisms of change in psychological treatment for pediatric anxiety/mood disorders. She also runs a small private practice.

Member for 15 years; CDLP awardee/mentor/co-chair; chaired Child & Adolescent Anxiety SIG and Early Career/Students SIGs; 2019 ADAA Emerging Leader Award. Ongoing focus: BIPOC Membership Scholarship and public/professional dissemination.

Allison LoPilato is Assistant Professor in the Emory Department of Psychiatry & Behavioral Sciences, Director of the Child & Adolescent Psychiatry Outpatient Clinic, and Co-Director of the Child & Adolescent Mood Program. Her research leverages computational models (e.g., reinforcement learning) and ambulatory assessment (EMA, passive sensing) to identify new intervention targets for youth mood disorders and suicide risk.

She holds an NIMH K23 award and leads multiple foundation grants on scalable care models. As a licensed clinical psychologist trained in CBT/DBT, she specializes in youth mood disorders, emotion dysregulation, and suicidality, and provides regional/national trainings. Member since 2017; joined the Board in 2024.

“I am excited and honored to serve an organization that fosters collaboration between researchers and clinicians and to represent the early-career voice as ADAA’s landscape evolves.”

Dr. Vasiliki Michopoulos is Associate Professor, Psychiatry & Behavioral Sciences at Emory and Core Scientist at the Emory National Primate Research Center. Her translational research investigates how psychosocial stress and trauma across the lifespan contribute to health inequities, spanning non-human primates (ENPRC) and humans (Grady Trauma Project).

Methods include social behavioral paradigms, hormone manipulation, dietary interventions, psychophysiology, neuroimaging, psychoimmunology, and behavioral neuroendocrinology. Funded by NIH (NIA, NIMH). Member since 2013; joined the Board in 2024.

“ADAA is my professional home… I hope to help grow ADAA by increasing diversity in disciplines and membership.”

Dr. Martin P. Paulus is a psychiatrist, neuroscientist, and ADAA Board member. As Scientific Director and President of LIBR in Tulsa, he leads a team using fMRI, computational modeling, and machine learning to clarify how decision making, reward processing, and interoception go awry in anxiety/depressive disorders. He has authored 475+ peer-reviewed papers and is Deputy Editor of JAMA Psychiatry.

His group develops precision psychiatry tools (e.g., real-time fMRI neurofeedback, non-invasive focused ultrasound) to modulate implicated brain circuits. By coupling EHR analytics with lab studies, he seeks biomarkers that predict treatment response across medications, psychotherapies, and neuromodulation. Member since 2008; past Chair of ADAA’s Scientific Council.

Dr. Michelle A. Patriquin, PhD, ABPP, is the John S. Dunn Distinguished Professor and an Associate Professor in the Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences at McGovern Medical School at UTHealth Houston. She also serves as the Assistant Dean of Digital Health & Innovation at the UTHealth Houston School of Behavioral Health Sciences and Co-Director of Research at the John S. Dunn Behavioral Sciences Center.

Dr. Patriquin is a board-certified and licensed clinical psychologist whose research examines subjective and biological outcomes and translates these discoveries into actionable mental health interventions. She has a particular focus on inpatient and intensive mental health care, leading efforts to bring cutting-edge science and digital health technologies into real-world hospital settings. Through this work, her goal is to improve patient safety, accelerate recovery, and increase access to high-quality, measurement-based intensive mental health care. She has authored more than 185 publications and presentations, co-edited a textbook, and edited several special issues of academic journals.

Her research has been supported by the NIH, NSF, Wellcome, PCORI, and major foundations, and she has received numerous awards for her contributions to research and mentorship. In addition, Dr. Patriquin serves on the boards of several national non-profit organizations committed to advancing mental health research, clinical care, and education.

Through her work, Dr. Patriquin is dedicated to improving outcomes for individuals during their most vulnerable times—ensuring that advances in research and technology translate into compassionate, effective mental health care when it is needed most.

Dr. Victoria Risbrough holds a dual appointment at San Diego VA Healthcare Services and UC San Diego. At the VA, she is Co-Director of Clinical Neuroscience, Center of Excellence for Stress and Mental Health, and a VA Research Career Scientist. At UCSD she is Professor, Vice Chair of Academic Affairs for Psychiatry, and Co-Director of Faculty Mentor Training.

Her dual preclinical/clinical program investigates mechanisms and treatments for anxiety/depression, especially trauma-related disorders, using homologous physiological/behavioral measures across rodents and humans. Clinical work includes the Marine Resiliency Study. She serves on ADAA’s Scientific Council, is a Fellow of ACNP, and Associate Editor of Neurobiology of Stress. Member since 2005; Board since 2024.

Alicia E. Meuret, PhD is Professor of Psychology at SMU, Director of the Anxiety and Depression Research Center (ARC), and a licensed psychologist. Doctoral training at Stanford (Psychiatry); postdoc at Harvard/Boston University. Her program focuses on novel treatments for anxiety and severe depression/anhedonia, biomarkers and fear-extinction mechanisms, and affective dysregulation. Developer of Capnometry-Assisted Respiratory Training (CART).

She has 100+ publications and 200+ presentations; funding > $10M (NIH and others); serves as advisor to NIH/AHRQ and ADAA; multiple awards and editorial roles. Media: NPR, WSJ, TIME, The Atlantic. ADAA member since 2002; current Scientific Council Chair and Ex-Officio Board Member.

Stephen M. Strakowski, MD is Professor and Vice Chair, Research of Psychiatry at IUSM; Professor of Psychiatry and Associate Vice President, Regional Mental Health at UT Austin Dell Medical School. Former Vice Dean for Research at Dell and the University of Cincinnati; previously Senior VP of Strategy at Cincinnati. Treasurer, National Network of Depression Centers; Director of Strategy, American Brain Coalition.

Internationally recognized expert in bipolar and mood disorders; leads research on treatment, outcomes, and neurobiology; advances racial equity in psychiatry and service delivery. Recognized as Best Doctor® and US News Top 1% Psychiatrist. 

“I am honored to lead ADAA’s new journal to impact lives through evidence-based science.”

Michael Gleason leads Consumer Brands, LLC; subsidiary Healthcare Brands publishes a network of healthcare websites including Anxiety.org. A scientist and entrepreneur, he previously built and sold two technology companies and worked in Washington, D.C. on energy and policy initiatives.

He holds an M.S. in Physical Chemistry from MIT and a B.S. from UCLA. He serves on the board of the Orange County School of the Arts Foundation and founded Work.org to create workforce centers for military families. Joined the ADAA Board in 2017 as an Honorary Member.

Helen Blair Simpson, M.D., Ph.D. is Professor of Psychiatry in the Department of Psychiatry at Columbia University Irving Medical College (CUIMC), Director of the Center for the OCD and Related Disorders at the New York State Psychiatric Institute, and co-research director of the New York-Presbyterian Center for Youth Mental Health. Funded by NIMH since 1999, she uses clinical trials to identify the best treatments for anxiety and OCD and partners with neuroscientists to elucidate how the brain produces anxiety, obsessions, and compulsions.

She currently leads an NIMH-funded grant to identify brain signatures of OCD with global collaborators. She partners with New York State to train front-line clinicians in early detection and treatment of OCD. She serves as Associate Editor of JAMA Psychiatry and is Immediate Past President of ADAA. An advisor to WHO on OCD classification and author of the APA Practice Guidelines for OCD, Dr. Simpson works to transform care for people with anxiety and OCD.

Dr. Simpson graduated summa cum laude from Yale, completed the MD-PhD program at The Rockefeller University/Cornell (PhD in basic neuroscience), and trained in psychiatry at Columbia University/New York-Presbyterian Hospital. She joined the Anxiety Disorders Clinic in 1996, later served as its Director (2006-2016), then Vice Chair for Research at Columbia Psychiatry and Director of Psychiatric Research at NYSPI (2017-2022), and Interim Chair of Psychiatry/Interim Director of NYSPI (2022-2023).

Member of ADAA since 2003; currently ADAA Immediate Past President.

Charles B. Nemeroff is the Matthew P. Nemeroff Professor & Chair, Department of Psychiatry & Behavioral Sciences, and Director, Institute for Early Life Adversity Research and Co-Director, Center for Psychedelic Research and Therapy at UT Austin Dell Medical School. Formerly Chair at University of Miami. Past President of the American College of Psychiatrists and ACNP.

His research focuses on neurobiology of mood/anxiety disorders, especially long-term consequences of childhood abuse/neglect. He has published 1100+ papers and 17 books; member of the National Academy of Medicine. Member since 1999; ADAA President (2021-2023) and CMO (2019-2021). He launched ADAA’s journal Journal of Mood & Anxiety Disorders and spearheaded The Patient Guide to Mood and Anxiety Disorders (2024).

Director, Community Psychiatry PRIDE; MGH Research Scholar (2020–2025). Her work focuses on implementing empirically supported treatments for anxiety disorders in community clinics, reducing disparities among low-income and minority patients. ADAA member since 2008; Board President 2019–2021.

Medical Director, The Ross Center; Assistant Clinical Professor, Psychiatry & Behavioral Sciences, The George Washington University. Psychiatrist specializing in assessment and pharmacologic management of anxiety/mood disorders in adults; named Washingtonian “Top Doctor.” Active ADAA member since 2004; President 2018–2019.